Carvedilol Tablet, Film Coated
Product Images NDC 50090-1067

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 50090-1067). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 01)
Chemical structure of Carvedilol, showing its molecular arrangement with functional groups including hydroxyl, methoxy, and aromatic rings.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 02)
A line graph comparing percentage mortality over time (in months) between Carvedilol and placebo groups. The x-axis represents months from 0 to 21, and the y-axis shows % mortality from 0 to 30%. The Carvedilol group consistently displays lower mortality percentages than the placebo group, with a noted p-value of 0.0014 indicating statistical significance.*
FDA Label Image

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)

Carvedilol Tablets (B1fa8af3 9789 45d2 8b77 A53935c52b49 03)
A forest plot showing hazard ratios with 95% confidence intervals for various subgroups including men, women, age groups, racial groups, diabetic status, ischemic status, heart rate categories, systolic blood pressure levels, and spironolactone use. The x-axis represents hazard ratio values from 0.0 to 2.0, with a vertical reference line at 1.0.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 04)
A line graph depicting percent mortality over a 24-month period comparing Carvedilol and placebo groups. The x-axis represents months, and the y-axis represents percent mortality. The graph shows lower mortality in the Carvedilol group compared to placebo over time, with a significance value (P = 0.03) indicated.*
FDA Label Image

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)

Structured Formula For Carvedilol (B1fa8af3 9789 45d2 8b77 A53935c52b49 05)
A forest plot showing hazard ratios with confidence intervals for various patient subgroups. The subgroups include age, gender, prior myocardial infarction timing, prior use of IV/oral beta blockers, Killip classification, thrombolytic therapy, percutaneous coronary intervention, current or prior congestive heart failure, diuretics use during myocardial infarction, angina presence, hypertension, diabetes status, heart rate, systolic blood pressure, and all patients combined. Two panels present results for different subgroup analyses.*
FDA Label Image

Label Image (Lbl500901067)

Label Image (Lbl500901067)
Carvedilol 12.5 mg film-coated tablets packaging label from A-S Medication Solutions. The label includes storage instructions to keep the product at 68 to 77 degrees Fahrenheit and protect from moisture. The package contains 60 tablets and has the NDC number 50090-1067.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.